ArticleExperimental and therapeutic medicine2020

Irbesartan ameliorates myocardial fibrosis in diabetic cardiomyopathy rats by inhibiting the TGFβ1/Smad2/3 pathway.

Min Zong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.